Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 531

1.

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.

Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ; PainFREE Rx II Investigators.

Circulation. 2004 Oct 26;110(17):2591-6. Epub 2004 Oct 18.

PMID:
15492306
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.

Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO; PainFREE Investigators.

Circulation. 2001 Aug 14;104(7):796-801.

PMID:
11502705
[PubMed - indexed for MEDLINE]
Free Article
4.

A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.

Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, Mascia F, Pensabene O, Giglia S, Chiarandà G, Vaccaro I, Mangiameli S, Corrao D, Santi E, Grammatico A; PITAGORA ICD Study Investigators.

Circ Arrhythm Electrophysiol. 2009 Apr;2(2):146-53. doi: 10.1161/CIRCEP.108.804211. Epub 2009 Feb 13.

PMID:
19808459
[PubMed - indexed for MEDLINE]
Free Article
5.

Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.

Wathen M.

Am Heart J. 2007 Apr;153(4 Suppl):44-52. Review.

PMID:
17394902
[PubMed - indexed for MEDLINE]
6.

Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.

Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL.

Heart Rhythm. 2010 Mar;7(3):353-60. doi: 10.1016/j.hrthm.2009.11.027. Epub 2009 Dec 2.

PMID:
20185109
[PubMed - indexed for MEDLINE]
7.

Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D Trial.

Lunati M, Defaye P, Mermi J, Garcia-Alberola A, Merino JL, Arenal A, Cappato R, Navarro X, Passardi M, Santini M.

Pacing Clin Electrophysiol. 2006 Dec;29 Suppl 2:S35-9. Review.

PMID:
17169131
[PubMed - indexed for MEDLINE]
8.

Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.

Grimm W, Plachta E, Maisch B.

Pacing Clin Electrophysiol. 2006 Jul;29(7):759-64.

PMID:
16884513
[PubMed - indexed for MEDLINE]
9.

BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial.

Gasparini M, Anselme F, Clementy J, Santini M, Martínez-Ferrer J, De Santo T, Santi E, Schwab JO; ADVANCE CRT-D Investigators.

Am Heart J. 2010 Jun;159(6):1116-1123.e2. doi: 10.1016/j.ahj.2010.02.007.

PMID:
20569728
[PubMed - indexed for MEDLINE]
10.

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK; PREPARE Study Investigators.

J Am Coll Cardiol. 2008 Aug 12;52(7):541-50. doi: 10.1016/j.jacc.2008.05.011.

PMID:
18687248
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.

Kouakam C, Lauwerier B, Klug D, Jarwe M, Marquié C, Lacroix D, Kacet S.

Am J Cardiol. 2003 Jul 1;92(1):26-32.

PMID:
12842240
[PubMed - indexed for MEDLINE]
12.

Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study.

Martins RP, Blangy H, Muresan L, Freysz L, Groben L, Zinzius PY, Schwartz J, Sellal JM, Aliot E, Sadoul N.

Europace. 2012 Oct;14(10):1457-64. Epub 2012 Apr 29.

PMID:
22547765
[PubMed - indexed for MEDLINE]
Free Article
13.

Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.

Sullivan RM, Russo AM, Berg KC, Stolen KQ, Seth M, Perschbacher D, Day JD, Olshansky B.

Heart Rhythm. 2012 Mar;9(3):351-8. doi: 10.1016/j.hrthm.2011.10.018. Epub 2011 Oct 19.

PMID:
22016074
[PubMed - indexed for MEDLINE]
14.

Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.

Saeed M, Neason CG, Razavi M, Chandiramani S, Alonso J, Natarajan S, Ip JH, Peress DF, Ramadas S, Massumi A.

J Cardiovasc Electrophysiol. 2010 Dec;21(12):1349-54. doi: 10.1111/j.1540-8167.2010.01825.x.

PMID:
20561107
[PubMed - indexed for MEDLINE]
15.

Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.

Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ, et al.

Circulation. 1992 Aug;86(2):363-74.

PMID:
1638705
[PubMed - indexed for MEDLINE]
16.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

PMID:
17470697
[PubMed - indexed for MEDLINE]
Free Article
17.

Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator.

Neglia JJ, Krol RB, Giorgberidze I, Mathew P, Lewis C, Munsif AN, Saksena S.

J Interv Card Electrophysiol. 1997 Feb;1(1):49-56.

PMID:
9869951
[PubMed - indexed for MEDLINE]
18.

Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.

Swerdlow CD, Peter CT, Kass RM, Gang ES, Mandel WJ, Hwang C, Martin DJ, Chen PS.

Circulation. 1997 Mar 18;95(6):1497-504.

PMID:
9118518
[PubMed - indexed for MEDLINE]
Free Article
19.

Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.

Sivagangabalan G, Eshoo S, Eipper VE, Thiagalingam A, Kovoor P.

Pacing Clin Electrophysiol. 2008 Sep;31(9):1095-9. doi: 10.1111/j.1540-8159.2008.01147.x.

PMID:
18834458
[PubMed - indexed for MEDLINE]
20.

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL; AVID Investigators.

J Cardiovasc Electrophysiol. 2003 Sep;14(9):940-8.

PMID:
12950538
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk